Khaberni - In a promising scientific step that could change the rules of prevention against respiratory epidemics, American ...

Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.

H5N1 avian influenza, often called bird flu, was first identified in the United States in 2014. Since then, the virus has moved beyond wild birds ...

As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts ...

Even though we are still in the early stages of the COVID-19 pandemic, scientists are trying to figure out the ways in which ...

Leyden Laboratories B.V. (the "Company" or "Leyden Labs") today announced landmark preclinical and clinical data in Science Translational Medicine supporting the development of their antibody-based ...

An antibody that has the power to neutralise any influenza strain could be widely administered in the form of a nasal spray ...

As a medical oncologist, Dr. Michael Grant’s patients fall into this group. He spoke with us about how he protects his patients from pneumonia and what he suggests when they have unexplained symptoms.

A Phase 2 trial is testing a weekly intranasal spray that primes early immune defenses to reduce respiratory virus illness.

Last year, at least one million people in the U.S. were hospitalized for respiratory virus illnesses like the flu or COVID-19, according to the Centers for Disease Control and Prevention.

Researchers developed an intranasal H5N1 vaccine that protected mice and hamsters from bird flu infection. The vaccine was ...

Last year, at least one million people in the U.S. were hospitalized for respiratory virus illnesses like the flu or COVID-19 ...